Live Breaking News & Updates on New Adjuvant Trial

Stay updated with breaking news from New adjuvant trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Translational Research in Oncology: TRIO Completes Enrollment of Phase III NATALEE Breast Cancer Clinical Trial


Translational Research in Oncology: TRIO Completes Enrollment of Phase III NATALEE Breast Cancer Clinical Trial
Over 5000 Patients Enrolled in 20 countries
EDMONTON, Alberta, April 21, 2021 (GLOBE NEWSWIRE) Translational Research In Oncology (TRIO) today announced completion of enrollment for Novartis phase III clinical trial of ribociclib with endocrine therapy in the adjuvant treatment of HR-positive, HER2-negative early breast cancer (EBC). The trial, referred to as NATALEE (New Adjuvant TriAl with LEE), has enrolled 5101 patients globally.
Rapid enrollment of this randomized, phase III study can be attributed to the strength of TRIO s global network consisting of 405 active investigator sites, including TRIO-US and its regional partners, and current unmet needs among the eBC patient population that includes intermediate-risk patients, as well as high-risk stage III patients. ....

United States , Jeff Legos , Kostenloser Wertpapierhandel , Launa Aspeslet , Dennisj Slamon , University Of California , Clinical Translational Research , Novartis Institutes For Biomedical Research , Astex Pharmaceuticals , Translational Research In Oncology , Head Of Oncology Drug Development , Los Angeles Jonsson Comprehensive Cancer Center , Research In Oncology , New Adjuvant Trial , Executive Director , Los Angeles Jonsson Comprehensive Cancer , Senior Vice President , Oncology Drug , Novartis Institutes , Biomedical Research , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப் லெகோஸ் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , மருத்துவ மொழிபெயர்ப்பு ஆராய்ச்சி , நோவர்த்திச் நிறுவனங்கள் க்கு உயிர் மருத்துவ ஆராய்ச்சி , மொழிபெயர்ப்பு ஆராய்ச்சி இல் புற்றுநோயியல் ,

Investegate |Translational Research in Onco Announcements | Translational Research in Onco: TRIO Completes Enrollment of Phase III NATALEE Breast Cancer Clinical Trial